A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
Clinical trial NCT00106847 · COMPLETED
Trial details
- NCT number
- NCT00106847
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 683
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.